“…With recent primary and post-hoc analytical literature (VANISH, VANCS, and ATHOS-3 randomized controlled trials) focusing on differences between the potential renal impact of norepinephrine with vasopressin in septic shock, the importance of reporting the vasopressor practices in observational studies akin to Todur et al can indeed not be undermined. 1 , 4 Of further note, the authors utilized the respective highest and the lowest 48 hours values of driving pressure and PaO 2 /FiO 2 on IMV, to compute the corresponding DRONE score while following up the serum creatinine trajectories of their patients till day 5 for AKI-subphenotype characterization, where the vasopressor-inotrope support would have also classified as a peculiarly dynamic parameter of prognostic importance. 1 To that end, it is only for the acknowledgement of the upcoming role of vasopressor quantification employing scoring systems norepinephrine equivalents (NEE), vasoactive-inotropic score (VIS), and cumulative vasopressor index), that the novel models like the MAVIC (mechanical ventilation, acute physiology and chronic health evaluation-III, vasopressors, inotropes, Charlson comorbidity index) are captivating enhanced attention for risk stratification in critical care.…”